About
About the Event
Get Involved
Event Features
Attendee List
Media Gallery
Meet the Team
Agenda
Search Agenda
Conference Programs
Symposia
Training Seminars
Keynotes
BuzZ Sessions
Speaker Biographies
Top Pharma
Sponsor/Exhibitor
Attendee Demographics + Event Features
Sponsorship Opportunities
Sponsor/Exhibitor Prospectus
Exhibit Contract
Current Sponsors
Exhibit Floorplan
Exhibit Services Schedule
Lead Generation Opportunities
Sponsor & Exhibitor Portal
Downloads
Brochures
Podcasts
Travel
Posters
Poster Winners
Poster Information
Poster Titles
Press
Newsroom
Media Partners
Press Pass
Register
Individual Pricing
Group Pricing
Post Event On-Demand
2018 Archived Content
OVERVIEW |
DOWNLOAD BROCHURE
|
SPEAKERS
|
SHORT COURSES
Confirmed Speakers
Derek Abbott, Ph.D., Director, Analytics, Amyris, Inc.
Sreedhara Alavattam, Ph.D., Principal Scientist and Senior Group Leader, Genentech, Inc.
Alina Alexeenko, Ph.D., Professor, School of Aeronautics and Astronautics, Purdue University
Afreen Allam, MBA, CEO & President, SiNON Therapeutics
Arun Alphonse Ignatius, Ph.D., Principal Scientist, Pfizer
Richard Altman, MS, Scientist, Protein Technologies, Amgen
Philip An, Scientist, Biologics, Amgen
Mark Arbing, Ph.D., Core Facility Director, UCLA-DOE Institute, University of California, Los Angeles
Frederick Arce-Vargas, M.D., Ph.D., Research Associate, University College London Cancer Institute, United Kingdom
Juan Aon, Ph.D., Senior Manager, MCCD, RD Biopharm, R&D, GSK
Paul Armistead, M.D., Ph.D., Associate Professor, Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
Tasneem Bahrainwala, PhD, Analytical Sciences Mass Spectrometry Group Leader, MacroGenics, Inc.
Yun Bai, Ph.D., Director, Ambrx, Inc.
Ramesh Baliga, Ph.D., Vice President, Discovery Biology, IGM Biosciences
Sashikanth Banappagari, Ph.D., Scientist II, Formulation Development, Vaccine Production Program/VRC/NIAID/NIH
Scott Banta, Ph.D., Professor, Chemical Engineering, Columbia University
Yoram Barak, Ph.D., Biosciences Innovation Manager, BASF Enzymes, LLC
Nicola Beaucamp, Ph.D., Head, Process Research, Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH
Stephen Beers, Ph.D., Associate Professor, Cancer Immunology and Immunotherapy, University of Southampton, United Kingdom
Robert D. Bell, Ph.D., Senior Principal Scientist, Neurovascular Biology Lab Head, Pfizer, Inc.
Frank Bernhard, Ph.D., Lab Leader, Institute of Biophysical Chemistry, Goethe University Frankfurt
Akhilesh Bhambhani, Ph.D., Principal Scientist & Group Leader, New Technologies-Vaccine Drug Product Development, Merck & Co., Inc.
David Bienvenue, Senior Director, Protein Sciences, Aptevo Therapeutics
Uli Binder, Ph.D., CTO, XL-Protein
Joerg Birkenfeld, Ph.D., Section Head, High Throughput Biologics, R&D Biologics Research/Protein Therapeutics, Sanofi-Aventis Deutschland GmbH
Eric Bishop, MBA, MSc, Vice President, Research & Development, Cygnus Technologies
Ruben Boado, Ph.D., Vice President, Research & Development/Co-Founder, ArmaGen, Inc.
Christopher Boddy, Ph.D., Professor & Director, Biochemistry Program, University of Ottawa
Berthold Boedeker, Ph.D., Chief Scientist, Global Biologics Development, Bayer Pharma AG
Jonathan Bones, Ph.D., Principal Investigator, Characterisation and Comparability Laboratory, National Institute for Bioprocessing Research and Training
Katherine Bowers, Ph.D., Principal Scientist, Group Leader, Analytical and Formulation Development, FUJIFILM Diosynth Biotechnologies
Andrew Bradbury, Ph.D., CSCO, Specifica, Inc
.
David Bramhill, Ph.D., Founder, Bramhill Biological Consulting, LLC
Christoph Brandenbusch, Ph.D., Group Leader, Biochemical and Chemical Engineering, Technical University, Dortmund, Germany
Juma Bridgewater, Ph.D., Senior Scientist, Analytical Sciences and Technology, Bristol-Myers Squibb
Ulrich Brinkmann, Ph.D., Expert Scientist, Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Center Munich
John Burke, Ph.D., Co-Founder, President, CEO, Applied BioMath, LLC
Marco Cacciuttolo, Ph.D., Head of Operations, Batavia Biosciences
William Callahan, Senior Scientist, Amgen
Julio A. Camarero, Ph.D., Professor, Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California
Marie Caparon, Ph.D., Associate Research Fellow, Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc
.
Paul J. Carter, Ph.D., Staff Scientist and Senior Director, Antibody Engineering, Genentech, Inc.
Mauro Castellarin, Ph.D., Postdoctoral Researcher, Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine
Steven Chamow, Ph.D., Principal Consultant, Chamow & Associates, Inc.
Wei-Chiang Chen, Ph.D., Scientist, Analytical Development, Biogen
Zhilei Chen, Ph.D., Associate Professor, Microbial Pathogenesis and Immunology, Texas A&M College of Medicine
David Chiu, Ph.D., Scientist, Analytical Sciences, Seattle Genetics
Yongku Cho, Ph.D., Assistant Professor, Chemical and Biomolecular Engineering, University of Connecticut
Partha Chowdhury, Ph.D., Senior Director and Head, Antibody Discovery, Sanofi Genzyme
Marcus T. Cicerone, Ph.D., Biomaterials Group, National Institute of Standards and Technology
Jeannick Cizeau, Ph.D., Director, Research, Eleven Biotherapeutics, Inc.
Bernardo Cordovez, Ph.D., President, Halo Labs
Tsafi Danieli, Ph.D., Director, BioGiv Excubator & Head, Protein Expression Facility, Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem
Gregory Daniels, M.D., Ph.D., Professor, Medicine, Moores Cancer Center, University of California, San Diego
Rebecca Davis-Harrison, Ph.D., Research Scientist, BioTechnology Discovery Research, Eli Lilly and Company
Kangwen Deng, Ph.D., Senior Scientist, Biologics, AbbVie
Mehabaw G. Derebe, Ph.D., Scientist, Biologics Engineering, Janssen BioTherapeutics
Jason DeVoss, Ph.D., Senior Scientist, Oncology, Amgen
Iskandar Dib, Ph.D., Principal Scientist DSP & Analytics, VTU Technology GmbH
Craig D. Dickinson, Ph.D., Senior Research Advisor, AME, Eli Lilly and Company
Gundo Diedrich, Ph.D., Associate Director, Antibody Engineering, MacroGenics, Inc.
Dimiter S. Dimitrov, Ph.D., Senior Investigator, Protein Interactions Section, Cancer and Inflammation Program, National Cancer Institute, NIH
Rakesh Dixit, Ph.D., DABT, Vice President, R&D, MedImmune/AstraZeneca
Robert Dream, Ph.D., Managing Director, HDR Company LLC
André C. Dumetz, Ph.D., Senior Scientific Investigator, Biopharm Downstream PD-3, R&D Platform Technology & Science, GlaxoSmithKline
Jiali Du, Ph.D., Scientist, Formulation Sciences, MedImmune
Mike Dyson, Ph.D., CTO, IONTAS, Ltd.
Mark Ellis, Principal Scientist, Protein Expression and Purification, UCB Pharma
Sam Ellis, Vice President, Thomson Instrument Company
Adam Feist, Ph.D., Project Scientist, Systems Biology Research Group, University of California
Timothy Fenn, Ph.D., Principal Scientist, Boehringer Ingelheim
Vasco Filipe, Ph.D., Lab Head, Pharmaceutical Development Biologics, Sanofi
Nicolas Fischer, Ph.D., Head, Research, Novimmune SA, Switzerland
Heather Flores, BS, Scientist, Technical Development Scientist, Late Stage Pharmaceutical Development, Genentech, Inc.
Søren Flygenring Basset, Ph.D., Director, R&D, Novo Nordisk Pharmatech A/S
Björn Frendéus, Ph.D., CSO, Bioinvent, Sweden
Timo Frensing, Ph.D., Senior Scientist, Cell Culture Research, Roche Diagnostics GmbH
Per-Ola Freskgard, Ph.D., Vice Director and Senior Leader, Neuroscience, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd.
Douglas Fuerst, Ph.D., Director, GSK Fellow, Advanced Manufacturing Technologies, GlaxoSmithKline
Peter Fung, Ph.D., Senior Manager, Product Marketing, NanoTemper Technologies
Julia Gavrilyuk, Ph.D., Principal Research Scientist, Chemistry Lead, Discovery Chemistry, Abbvie StemcentRx, Inc.
Paul Gianella, Ph.D., Postdoctoral Research Fellow, Amgen, Inc.
Henning Gieseler, Ph.D., CSO, Pharmaceutical Development, GILYOS GmbH
Ryan T. Gill, Ph.D., Slade Professor, Chemical and Biological Engineering, University of Colorado
Pierre-Alain Girod, CSO, Selexis
Adam Goldstein, MSc, Principal Scientist, Global Technology, Roche/Genentech
Christoph Goletz, Associate Director, Immunomodulation, Glycotope GmbH
Christopher H. Gray, Ph.D., Team Leader, Structural Biology, Drug Discovery Program, CRUK Beatson Institute
Karl E. Griswold, Ph.D., Associate Professor, Thayer School of Engineering, Dartmouth College
Flaviu Gruia, Ph.D., Principal Scientist, Drug Product Analytical Development, Moderna Therapeutics
Jijie Gu, Ph.D., Research Fellow and Function Head, Immunology Discovery, AbbVie Bioresearch Center
Kapil Gupta, Ph.D., Associate Director, Protein Pharmaceutical Development, Biogen
Claes Gustafsson, CCO & Founder, ATUM (formerly DNA2.0)
Shiang Gwee, Scientist, Drug Product Sciences, MacroGenics, Inc.
Andrew Holloway, Senior Research Associate, Analytical Sciences, Seattle Genetics, Inc.
Amy Han, Ph.D., Director, Chemistry, Regeneron Pharmaceuticals
Brian Hall, Ph.D., Principal Scientist, Biologics, Merck & Co.
Christian Harding, Ph.D., CSO, VaxNewMo
Feras Hatahet, Ph.D., Scientist, Protein Technologies, Amgen
Cheng Her, Ph.D., Postdoctoral Research Fellow, Carpenter Lab, Pharmaceutical Sciences, University of Colorado-Denver, Anschutz Medical Campus
Robert Herbst, Ph.D., Director, Process Development and Engineering, ImmunoGen, Inc.
Mark Hildebrand, Ph.D., Research Scientist and Director, Marine Biology Research Division, Scripps Institution of Oceanography, University of California, San Diego
Oliver Hill, Ph.D., Vice President, Molecular Biology/Protein Engineering, Apogenix AG
Sophia Hober, Ph.D., Professor, Molecular Biotechnology, KTH Royal Institute of Technology
Bushra Husain, Ph.D., Senior Scientific Researcher, Genentech, Inc.
Farren Isaacs, Ph.D., Assistant Professor, Molecular Cellular and Development Biology, Yale University
Jorge Iván Alvarez, Ph.D., Assistant Professor, Department of Pathobiology, University of Pennsylvania
Lavanya Iyer, Ph.D., Research Investigator, Bristol-Myers Squibb
Renaud Jacquemart, Ph.D., BioPharma Downstream Process Specialist, Natrix Separations
Harsh Jain, Ph.D., Visiting Associate, FDA
Jacob Janey, Ph.D., Associate Director, BMS
Miroslaw Janowski, M.D., Ph.D., Associate Professor, Radiology, Johns Hopkins University
Donald L. Jarvis, Ph.D., Professor, Molecular Biology, University of Wyoming
Ben Jeyaretnam, E&L Analytical Lead, Sanofi
Haiyan Jiang, Ph.D., Principal Scientist, Biologics Research, Janssen BioTherapeutics, Janssen R&D
Nathan H. Joh, Ph.D., Scientist, Attribute Sciences, Amgen
Matt Johnson, Ph.D., CSO, Avacta Life Sciences
Aled Jones, Senior Product and Applications Manager, ProZyme
Sagar Kathuria, Ph.D., Senior Scientist, Protein Engineering, Sanofi Genzyme
John K. Kawooya, Ph.D., Director, Biologics Optimization, Discovery Research, Amgen
Alex Kelly, Business Development Manager, Retrogenix Limited
Eric Kelsic, Ph.D., Staff Scientist, George Church Laboratory, Wyss Institute, Harvard Medical School
Kristin Kemmerich, Ph.D., Head, Antibody Generation Section, National Research Council Canada
Christopher Kemp, Ph.D., President, Kempbio
Sophia Kenrick, Ph.D., Senior Applications Scientist, Wyatt Technology
Tarik Khan, Ph.D., Group Leader, Late-Stage Pharmaceutical and Processing Development, F. Hoffmann-La Roche Ltd., Switzerland
Maura Kibbey, Ph.D., Director, Global Biologics, U.S. Pharmacopeia
Takanori Kigawa, Ph.D., Team Leader, Quantitative Biology Center, RIKEN
Yoshimi Kikuchi, Ph.D., Executive Professional and Group Manager, Recombinant Protein Research Group, Material Development & Application Labs, Ajinomoto Co., Inc.
Philip M. Kim, Ph.D., Associate Professor, Computational and Integrative Biology, University of Toronto, Canada
Yong-Sung Kim, Ph.D., Professor, Molecular Science and Technology, Ajou University, Korea
Jonathan S. Kingsbury, Ph.D., Principal Scientist, Global Pharmaceutical Development Biologics, Sanofi
Marina Kirkitadze, Ph.D., Deputy Director, Head of Biophysics and Conformation Unit, Analytical R&D Biochemistry, Sanofi Pasteur, Canada
Uday Kishore, Ph.D., Associate Professor, Biosciences, Brunel University London
Georg Klima, Dipl. Ing., Executive Director, Process Science, Boehringer Ingelheim RCV GmbH & Co. KG
Manfred Konrad, Ph.D., Research Director, Enzyme Biochemistry, Max Planck Institute for Biophysical Chemistry
Marie Kosco-Vilbois, Ph.D., CSO, NovImmune SA
Thomas E. Kraft, Ph.D., Postdoctoral Scientist, Large Molecule Research, Roche Diagnostics GmbH
Simon Krah, Ph.D., Senior Scientist, Protein Engineering and Antibody Technologies, Merck KGaA, Germany
Steffen Kreye, Ph.D., Associate Director, USP, Glycotope GmbH
Claus Kristensen, Ph.D., CEO, GlycoDisplay Aps
Yoichi Kumada, Ph.D., Associate Professor, Department of Functional Chemistry, Kyoto Institute of Technology
Steven LaBrenz, Ph.D., Scientific Director, Cell and Developability Sciences, PDMS, Janssen R&D
Eilyn R. Lacy, Ph.D., Principal Scientist, Janssen BioTherapeutics (JBIO), Janssen Research & Development, LLC
James Lalonde, Ph.D., Senior Vice President, R&D, Codexis
Lois A. Lampson, Ph.D., Emeritus Associate Professor of Neurosurgery, Brigham & Women’s Hospital/Harvard Medical School
Olga S. Latinovic, Ph.D., Assistant Professor and Head, Lab for Imaging Studies of Pathogens & Cell Interactions and IHV Imaging Facility, Institute of Human Virology and Microbiology and Immunology, University of Maryland School of Medicine
Thomas Laue, Ph.D., Professor Emeritus, Molecular, Cellular and Biomedical Sciences, University of New Hampshire
Gyun Min Lee, Ph.D., Professor, Biological Sciences, KAIST
Jonas Lee, Ph.D., Scientist, Amgen
Toni Lee, Ph.D., Senior Scientist, Biocatalysis, Provivi
Ming Lei, Ph.D., Associate Scientist, Protein Analytical Chemistry, Genentech
Kin-Mei Leung, Ph.D., Principal Scientist, Drug Discovery, F-star Biotechnology, Ltd.
Nathan E. Lewis, Ph.D., Assistant Professor, Department of Pediatrics, University of California, San Diego
Kim Li, Ph.D., DABT, MPH, Senior Manager, Environment, Health, Safety and Sustainability Product Stewardship Toxicology, Amgen
John Löfblom, Ph.D., Associate Professor, Protein Technology, Biotechnology, KTH Royal Institute of Technology
Urs Lohrig, Ph.D., Labhead, Phys. Chem. Characterization, Biosimilars, Biologics Technical Development & Manufacturing, Sandoz GmbH
Thorsten Lorenz, Ph.D., Global Head, Developability Assessment, Integrated Biologics Profiling, Novartis Pharma AG
Nikolai Lorenzen, Ph.D., Large Protein Biophysics, Novo Nordisk A/S
Xiaofeng Lu, Ph.D., Principal Research Scientist, Pharmaceutical Development, AbbVie, Inc.
Haibin Luo, Ph.D., Scientist II, MedImmune LLC
Jacob Luoma, Engineer II, Pharmaceutical Processing and Technology Development, Genentech
Stefan Lutz, Ph.D., Professor and Department Chair, Department of Chemistry, Emory University
Haripada Maity, Ph.D., Research Advisor, Formulation Development, CMC Development, Eli Lilly and Company
Anne Marcil, Team Lead, Monoclonal Antibodies, National Research Council, Canada
Thomas Martens, Principal Scientist, Unchained Labs
Allan Matte, Ph.D., Senior Research Officer, Downstream Processing & Analytics, Human Health Therapeutics, National Research Council Canada (NRC-CNRC)
Kevin Mattison, Principal Scientist, Bioscience, Malvern PANalytical
John McCafferty, Ph.D., CEO, Antibody Engineering, IONTAS, Ltd.
Karen McDonald, Ph.D., Professor, Chemical Engineering, University of California, Davis
Matthew McGann, Field Applications Manager, Biosciences, Malvern PANalytical
Colin Medley, Ph.D., Senior Scientist, Small Molecule Pharmaceutical Sciences, Genentech, Inc.
Torben Moos, M.D., Ph.D., DMSc, Professor, Medicine and Health Technology, Aalborg University
Charles Moore, Ph.D., Research Investigator, Novartis
Phil Morton, Ph.D., Science Director, Bioprocess Characterisation, Albumedix
Thomas Müller-Späth, Ph.D., Senior Scientist, Institute for Chemical and Bioengineering, ETH Zürich
Eric J. Munson, Ph.D., Patrick DeLuca Endowed Professor, Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky
Nikhil Ramsubramaniam, Ph.D., Senior Scientist, Merck
Madhu Natarajan, Ph.D., Preclinical Therapeutic Area Head, Ophthalmology & Complement Biology, Shire
Peter Neubauer, Ph.D., Professor, Department of Bioprocess Technology, Institute of Biotechnology, Technische Universität Berlin
Juergen Nett, Ph.D., Director, High Throughput Expression, Adimab, LLC
David Nicoli, Ph.D., Vice-President R&D, Particle Sizing Systems LLC
Dennis Niermeier, MSc, IBA Lifesciences
Vaheh Oganesyan, MS, Scientist, MedImmune
Teruyo Ojima-Kato, Ph.D., Researcher, Meijo University
Adekunle O. Onadipe, Ph.D., Associate Research Fellow, Cell Line Development, Bioprocess R&D, Pfizer
Marcin Paduch, Ph.D., Pipeline Director, Recombinant Antibody Network, University of Chicago
Tadas Panavas, Ph.D., Senior Principal Scientist, Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals, Inc.
Dimitris Papamichail, Ph.D., Assistant Professor, Computer Science, The College of New Jersey
Niv Papo, Ph.D., Group Leader and Assistant Professor, Biotechnology Engineering, Ben-Gurion University
Diane Paskiet, MS, Director of Scientific Affairs, Scientific Affairs and Technical Services, West Pharmaceutical Services
Edward F. Patz, Jr., M.D., Professor, Radiology, Pharmacology and Cancer Biology Duke University Medical Center
Li Peng, Ph.D., Vice President, Antibody Engineering and Protein Sciences, Palleon Pharmaceuticals
Robert Pejchal, Ph.D., Scientist, Antibody Engineering, Adimab LLC
Robert Peters, Ph.D., Senior Vice President, Research, Bioverativ, Inc.
Mario Pereira, Ph.D., Senior Scientist, Horizon Discovery
Didier Pertuy, Vice President, Global Drug Device Integrated Development & Device Strategy, Sanofi, France
Samuel Pollock, Researcher, Pharmaceutical Chemistry, University of California, San Francisco
Dennis Powers, Director, Sales Engineering, G-CON Manufacturing
James R. Prudent, Ph.D., President & CEO, Centrose LLC
Enrico Purisima, Ph.D., Team Leader, Molecular Modeling, National Research Council Canada
Laszlo Radvanyi, Ph.D., Senior Vice President, Senior Scientific Advisor, Immunology, Immuno-Oncology, EMD Serono R&D Institute (a business of Merck KGaA, Darmstadt, Germany)
Czeslaw Radziejewski, Ph.D., Senior Principal Research Scientist, Biophysical Chemistry, AbbVie
Smita Raghava, Ph.D., Senior Scientist, Sterile Formulation Sciences, Merck & Co.
G. Jonah Rainey, Ph.D., Executive Director, Research, MabVax Therapeutics Holdings, Inc.
Alexey Rak, Ph.D., Head of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D
Srivatsan Raman, Ph.D., Assistant Professor, Departments of Biochemistry & Bacteriology, University of Wisconsin-Madison
Servio Ramirez, Ph.D., Associate Professor, Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University
Theodore W. Randolph, Ph.D., Kenneth and Genevieve Gillespie Professor, Department of Chemical and Biological Engineering, University of Colorado, Boulder
Helen Rawsthorne, Ph.D., Senior Research Scientist, Molecular Biology and Fermentation, Albumedix
Wayne F. Reed, Ph.D., Professor, Physics, Tulane University
Christoph Reese, Ph.D., Director, Microbial Fermentation, Roche Diagnostics GmbH
Dorothea Reilly, Ph.D., Principle Scientist and Associate Director, Early Stage Cell Culture, Genentech
Nigel F. Reuel, Ph.D., Assistant Professor, Chemical and Biological Engineering, Iowa State University
Joël Richard, Ph.D., Vice President, Peptides, CMC & Engineering, Ipsen
Jerome Robert, PhD, Pathology and Laboratory Medicine, Djavad Mowafaghian Centre for Brain Health, University of British Columbia
Gabriel Rocklin, Ph.D., Senior Fellow, Biochemistry & Bioengineering, University of Washington
Miguel Ângelo Rodrigues, Ph.D., Researcher and Invited Professor, Chemical Engineering, Instituto Superior Técnico, University of Lisbon
Floyd Romesberg, Ph.D., Professor, Chemistry, The Scripps Research Institute
Enrique Miranda Rota, Ph.D., Research Associate, University College London Cancer Institute
Alice Rothnie, D.Phil., Lecturer, Biochemistry, Life & Health Sciences, Aston University
David Rozzell, Ph.D., Senior Vice President, Biocatalysis, Provivi
Kevin Rust, Ph.D., Principal Scientist, Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc.
Natalie Saez, Ph.D., Senior Research Officer, Institute for Molecular Bioscience, The University of Queensland
Miguel Saggu, Scientist, Late Stage Pharmaceutical Development, Genentech
Andrey G. Sarafanov, Ph.D., Chemist, Principal Investigator, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA)
Prasad Sarangapani, Ph.D., Staff Scientist, Protein Biochemistry, Regeneron Pharmaceuticals
Jonas Schaefer, Ph.D., Head, High-Throughput Binder Selection Facility, Biochemistry, University of Zurich
Volker Schellenberger, Ph.D., President and CEO, Amunix
Michael Schirm, Ph.D., Associate Director, R&D Proteomics, CAPRION BIOSCIENCES INC.
Tilman Schlothauer, Ph.D., Principal Scientist, Biochemical and Analytical Research, Large Molecule Research, Roche Innovation Center Munich
Stefan Schmidt, Ph.D., MBA, CSO, Development and Innovation, Rentschler Biotechnology
Christian Schoneich, Ph.D., Distinguished Professor and Chair, Pharmaceutical Chemistry, University of Kansas
Lynette Schroeter, Crystalomics, Group Lead, Formulations Development, Althea CMO
Ian Schwartz, MS, CMC Expert, Antibody Drug Conjugate and Upstream/Downstream Process Development, Tech Transfer, and Manufacturing Ops, Sartorius Stedim Biotech
Sebastian Schuck, Ph.D., Head, Business Development, Wacker Biotech GmbH
Carolin Sellmann, Ph.D., Scientist, Protein Engineering and Antibody Technologies, Merck KGaA
Saurabh Sen, Ph.D., Principal Scientist, Biotherapeutics Discovery, Boehringer Ingelheim
Dinen Shah, Department of Pharmaceutical Sciences (Krishna Mallela Lab), University of Colorado Denver Health Sciences Center
Justin Siegel, Ph.D., Assistant Professor, Biochemistry & Molecular Medicine, UC Davis Genome Center
Michael Sierks, Ph.D., Professor, Chemical Engineering, Arizona State University
Michael Siedler, Ph.D., Head, NBE High-Throughput and Advanced Formulation Sciences, Drug Product Development, AbbVie Deutschland GmbH & Co. KG
Ian Shieh, Ph.D., Scientist, Genentech
Judy Shimoni, Ph.D., Principal Scientist and Group Leader, Protein Analytical Chemistry, Genentech, Inc., a member of the Roche Group
Nigel Shipston, Ph.D., Director of Program Design, FUJIFILM Diosynth Biotechnologies
Christopher Smith, Ph.D., Senior Scientific Consultant, Biologics, Genedata
Eric Smith, Ph.D., Director, Bispecific Antibdies, Regeneron Pharmaceuticals, Inc.
Chris Spahr, Senior Scientist, Therapeutic Discovery, Discovery Attribute Sciences, Amgen, Inc.
Jason Stewart, BS, Senior Associate Scientist, Pharmaceutical Research and Development, Pfizer, Inc.
Lars Stöckl, Ph.D., Director, Glycoprotein Development and PTM Analytics, Glycotope GmbH
Kevin Strozyk, Sr. Research Associate, Analytical Sciences, Seattle Genetics
Shanmuuga T. Sundaram, Ph.D., Research Advisor, BioAnalytical Sciences, Bioproduct Research and Development, Eli Lilly and Company
David E. Szymkowski, Ph.D., Vice President, Cell Biology, Xencor, Inc.
Saurabh Sen, Ph.D., Principal Scientist, Biotherapeutics Discovery, Boehringer Ingelheim
Feng Shu, Ph.D., Senior Researcher, Chugai Pharmabody Research, Singapore
Ken Skidmore, Technical Development Scientist, Protein Analytical Chemistry, Genentech
Le Sun, PhD, CEO, AbMax Biotechnology
Michael Swanson, Ph.D., Senior Scientist, Merck
Rastislav Tamaskovic, Ph.D., Senior Scientist, Biochemistry, University of Zurich
Jamshid Tanha, Ph.D., Senior Research Officer, Human Health Therapeutics Portfolio, National Research Council Canada
Hanna Tegel, Ph.D., Scientist and Group Leader, Biotechnology, Proteomics and Nanobiotechnology, KTH Royal Institute of Technology
Devin Tesar, Ph.D., Scientist, Drug Delivery, Genentech
Holger Thie, Ph.D., Associate Director, Molecular Biology, Early Stage Bioprocess Development, Boehringer Ingelheim Pharma GmbH & Co. KG
Jonas Hoeg Thygesen, Ph.D., Area Specialist, R&D - Microanalysis Centre, Novo Nordisk Pharmatech
Elizabeth M. Topp, Ph.D., Dane O. Kildsig Chair and Department Head, Department of Industrial and Physical Pharmacy, Purdue University
Riccardo Torosantucci, Ph.D., Head of Laboratory Formulation Development, Pharmaceutical Development Biologics, Sanofi-Aventis Deutschland GmbH
Nicholas Turner, Ph.D., Professor, Chemical Biology, University of Manchester
Thomas J. Van Blarcom, Ph.D., Associate Research Fellow, Rinat Laboratories, Oncology Research and Development, Pfizer, Inc.
Ewald Van den Bremer, Ph.D., Senior Scientist, Genmab A/S
Floris Van Delft, Ph.D., Founder & CSO, SynAffix BV
James Van Deventer, Ph.D., Assistant Professor, Chemical and Biological Engineering, Tufts University
Dmitry G. Vassylyev, Ph.D., Professor, Biochemistry and Molecular Genetics, University of Alabama at Birmingham
Pandurangan Vijayanand, M.D., Ph.D., Associate Professor, Vaccine Discovery, La Jolla Institute for Allergy and Immunology
Bjørn Voldborg, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Moritz Von Stosch, Ph.D., Senior Manager, Fermentation, Technical R&D, GSK Vaccines
Jonathan Wall, Ph.D., Professor and Director, Amyloidosis and Cancer Theranostics Program, University of Tennessee Medical Center
Frank S. Walsh, Ph.D., CEO, Ossianix
Tianyi Wang, Ph.D., Scientist, R&D, Sorrento Therapeutics
E. Sally Ward, Ph.D., Professor, Molecular and Cellular Medicine, Texas A&M Health Science Center
SiowFong Wee, Ph.D., Director, Formulation, Analytical & Bioassay, Aptevo Therapeutics
Stefan Weigand, Ph.D., Head, Large Molecule Research, Roche Innovation Center, Roche Pharma
Andrew Weinberg, Ph.D., Judy Ann Hartmann Endowed Chair for Cancer Immunology Research, Robert W. Franz Cancer Research Center
David Weiner, Ph.D., Vice President, Technology & Product Development, BASF Enzymes, LLC
Mark Welch, Ph.D., Vice President, Research and Development, ATUM (formerly DNA2.0)
James A. Wells, Ph.D., Professor, Pharmaceutical Chemistry, University of California, San Francisco
Tim Wenzel, Scientist, Ph.D. Candidate, University of Erlangen GILYOS GmbH
David Wood, Ph.D., Professor, Professor, Chemical & Biomolecular Engineering, The Ohio State University
Dongxin Zhao, Ph.D., Postdoctoral Fellow, Prashant Mali Lab, Department of Bioengineering, University of California, San Diego
Gregory A. Weiss, Ph.D., Professor, Chemistry and Molecular Biology & Biochemistry, University of California, Irvine
Helen Wu, Ph.D., Senior Scientist, Boehringer Ingelheim Pharmaceuticals Inc
Jiansheng Wu, Ph.D., Principle Scientific Manager, Protein Chemistry, Genentech, Inc.
Zhen Wu, Ph.D., Senior Scientist, AbbVie
Mingjie Xie, MSc, MBA, CEO, Rapid Novor Inc
Yemin Xu, Ph.D., Senior Regulatory Scientist, Regulatory Science, Regeneron
Noriko Yamano, Ph.D., Senior Scientist, Manufacturing Technology Association of Biologics; Guest Academic Staff, Graduate School of Engineering, Osaka University
Danlin Yang, Ph.D., Scientist, Biophysics, Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals
Alexei Yeliseev, Ph.D., Staff Scientist, LMBB, NIH/ NIAAA
Mimi Cho Yung, Ph.D., Biomedical Staff Scientist, Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory
Alexandre Zanghellini, Ph.D., CEO, Arzeda
Qingchun Zhang, Ph.D., Senior Scientist, Amgen, Inc.
Wei Zhang, Ph.D., Mitacs Elevate Fellow, University of Toronto, Canada
Ali Zarrin, Ph.D., Senior Scientist, Immunology and Antibody Engineering, Genentech
Zhongqi Zhang, Ph.D., Scientific Director, Attribute Sciences, Process Development, Amgen
Huiman Zhao, Ph.D., Departments of Chemical and Biomolecular Engineering, Chemistry, and Biochemistry, Bioengineering, Institute for Genomic Biology, and Center for Biophysics and Computational Biology, University of Illinois
Haihong (Helen) Zhong, Ph.D., Senior Scientist, Oncology Research, MedImmune, Inc.
Qi (Tony) Zhou, Ph.D., Assistant Professor, Industrial and Physical Pharmacy, Purdue University
Kyle Zingaro, Ph.D., Development Scientist II, Early Stage Development, Alexion Pharmaceuticals
Jonathan Zmuda, Ph.D., Director, Cell Biology R&D, Thermo Fisher Scientific
Zhongcheng Zou, Ph.D., Staff Scientist, Structural Immunology Section, Lab of Immunogenetics, NIAID/NIH
#CHIPepTalk
Programs
(Re)Discovering Expression Platforms
Recombinant Protein Production Part 1
Recombinant Protein Production Part 2
Predictive Protein Production
Automation in Protein Sciences
Purification and Quality Assurance
ML and Predictive Methods
Methods for Developability Analysis
Characterization for Novel Biotherapeutics
Vectors for Targeted Delivery
Targeted Radioligand Therapies
Next-Generation Protein Degradation
Bispecific Engineering & Therapeutics
Introduction to Antibody Engineering
Antibody Drug Discovery
Formal lectures, interactive discussions and activities to maximize the learning experience - LEARN MORE